Financial Statements — LIEN
Balance Sheet
(in millions USD)| Metric | Q2
2026 | Q1
2026 | Q3
2025 | Q2
2025 | Q1
2025 | Q3
2024 | Q2
2024 | Q1
2024 | Q3
2023 | Q2
2023 | Q1
2023 |
|---|
| Cash & Equivalents | 0.93 | 3.35 | 10.46 | 13.83 | 14.92 | 30.11 | 34.00 | 33.16 | 29.82 | 32.90 | 32.54 |
| Total Assets | 343.96 | 373.13 | 327.25 | 331.75 | 313.70 | 89.28 | 90.08 | 90.35 | 89.19 | 91.34 | 89.99 |
| Total Liabilities | 41.47 | 68.95 | 24.33 | 29.91 | 12.68 | 6.74 | 5.82 | 5.83 | 1.78 | 1.29 | 1.16 |
| Retained Earnings | (0.82) | 0.88 | (0.46) | (1.54) | (2.36) | (2.55) | (0.83) | (0.57) | 2.30 | 4.94 | 3.73 |
| Total Stockholder Equity | 302.49 | 304.18 | 302.92 | 301.84 | 301.02 | 82.54 | 84.26 | 84.52 | 87.40 | 90.04 | 88.83 |
Income Statement
(in millions USD) (except per-share rows)| Metric | Q2
2026 | Q1
2026 | Q4
2025 | Q3
2025 | Q2
2025 | Q1
2025 | Q4
2024 | Q3
2024 | Q2
2024 | Q1
2024 | Q4
2023 | Q3
2023 | Q2
2023 | Q1
2023 |
|---|
| Selling, General & Admin | 1.14 | 1.21 | 1.21 | 1.08 | 1.37 | 0.97 | 0.70 | -- | -- | -- | 0.00 | 0.00 | 0.00 | 0.00 |
| Total Operating Expenses | -- | -- | -- | -- | -- | 4.27 | -- | -- | -- | -- | -- | -- | -- | -- |
| Net Income | 6.06 | 8.54 | 8.25 | 8.83 | 8.58 | -- | -- | (1.72) | (0.26) | (1.03) | (1.85) | (2.64) | 1.21 | 2.36 |
| Basic EPS | 0.27 | 0.37 | 0.36 | 0.39 | 0.38 | 0.33 | 0.67 | (0.03) | 0.21 | 0.08 | 0.41 | 0.20 | 0.19 | 0.38 |
| Diluted EPS | 0.27 | 0.37 | 0.36 | 0.39 | 0.38 | 0.33 | 0.67 | (0.03) | 0.21 | 0.08 | 0.41 | 0.20 | 0.19 | 0.38 |
Cash Flow Statement
(in millions USD)| Metric | Q2
2026 | Q1
2026 | Q4
2025 | Q3
2025 | Q2
2025 | Q1
2025 | Q4
2024 | Q3
2024 | Q2
2024 | Q1
2024 | Q4
2023 | Q3
2023 | Q2
2023 | Q1
2023 |
|---|
| Operating Cash Flow | 32.97 | (20.83) | (13.77) | (1.39) | 1.95 | (7.26) | (7.33) | (2.29) | 2.48 | 2.10 | 7.14 | 0.84 | 0.35 | (2.58) |
| Financing Cash Flow | (35.39) | 21.24 | 6.24 | (1.97) | (3.04) | (1.75) | 1.15 | (1.61) | (1.64) | (1.55) | (4.35) | (3.91) | 0.00 | 0.00 |
